ZBIO · Zenas BioPharma, Inc. · Investor Relations
$28.18
+1.47 (+5.50%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.87B
Shares
65.18M
Volume · Oct 20
544.54K
Avg daily vol (3M)
701.96K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-10-27 12:00 UTC | Virtual R&D Event | Webcast |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-29 | Obexelimab IgG4-RD Investor Event | Event |
| 2026-09-16 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-09-14 | Morgan Stanley 24th Annual Global Healthcare Conference | Conference |
| 2026-09-09 | Citi Biopharma Back to School Conference | Conference |
| 2026-06-15 | H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit | Webcast |
| 2026-02-11 | Guggenheim Emerging Outlook: Biotech Summit 2026 | Webcast |
| 2026-01-05 | Zenas BioPharma Phase 3 IgG4-RD Registration Trial Topline Results | Earnings call |
| 2025-12-03 | 8th Annual Evercore Healthcare Conference | Conference |
| 2025-11-18 | Jefferies Global Healthcare Conference in London | Conference |
| 2025-10-08 | Zenas BioPharma - Transformational Global Collaboration with InnoCare Pharma | Webcast |
| 2025-09-10 | Morgan Stanley 23rd Annual Global Healthcare Conference | Conference |
| 2025-09-03 | Cantor Global Healthcare Conference 2025 | Conference |
| 2025-09-02 | Citi's 2025 Biopharma Back to School Conference | Conference |
Source: https://investors.zenasbio.com/financial-information/sec-filings